title: High dose aerosol pentamidine for secondary Pneumocystis carinii pneumonia prophylaxis in AIDS patients.
abstract: In a prospective trial of aerosolized pentamidine as secondary prophylaxis for Pneumocystis carinii pneumonia (PCP) 18 patients received 400 mg once weekly for a mean period of 15.5 months. Pentamidine aerosol was administered with an MA2 jet nebulizer. No PCP relapses were observed and no serious side effects occurred.
authors.affiliation: Dept. of Infectious Diseases, Malmö General Hospital, University of Lund, Sweden.
authors.forename: L
authors.initials: L
authors.lastname: Flamholc
authors.forename: S
authors.initials: S
authors.lastname: Haidl
authors.forename: E
authors.initials: E
authors.lastname: Westin
authors.forename: L
authors.initials: L
authors.lastname: Borgdalen
authors.forename: T
authors.initials: T
authors.lastname: Prellner
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000336:Aerosols; D006801:Humans; D008297:Male; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011446:Prospective Studies
chemical_list: D000336:Aerosols; D010419:Pentamidine